logo

Twenty Stocks to Short Sell
By: Timothy Sykes   Wednesday, July 09, 2008 10:31 AM

Vote for next session
The next market session will close:

Just put ‘em all in a watchlist and watch ‘em…some will go nowhere, some will spike, some will drop…aim small, miss small, learn to understand the setups that lead to the biggest drops:

GETG had a nice reversal—thought about shorting into the clo0se, but now that Thinkorswim got strict about the Pattern Day Trader rule, I’m scared to short imperfect setups, kinda of a gift and a curse…no support til $3, definitely reserves shares for possible short

WLGC is a patent play, they typically runup nicely, but only if the volume is there and inevitably come crashing down, reserve shares to short just in case

ARTE whaaaat? Trying to make a cup & handle breakout right into resistance at $2? Wow, this would be pretty amazing, I just can’t believe it, reserve shares just in case this breakout attempt fails…hopefully it keeps goin cuz right now potential downside is shit

Ambac Financial Group, Inc. (ABK) is a distressed financial stock, not for me, gotta know what you’re good and not good at & stay disciplined

Radian Group Inc. (RDN) is the same exact thing, tempting, but no thanks…waaaay too new-related, I totally p refer pump and dumps and frauds, at least those guys don’t pretend to be competent

ERII was alerted, traded and written about….good god, this was a nice 15-20%…now, who knows, lots of bitter shareholders, even more people believing it’ll spike again…I just don’t care, I go for that initial pop cuz it’s more predictable. Avoid. 

NCEY had that nasty financial filing, it’s dead to me…and probly to the world now…try to reserve shares to short as this could really go under 20 or even 10 cents in the next few weeks

GigaMedia Limited (GIGM) is my #1 potential short today, resistance just under $15, I hope it gets there as then it’d be an easy $1-2 pullback…probly…definitely reserve shares early as it’s on everyone’s radar considering how junkie the company is.

Hemispherx BioPharma, Inc (HEB) had positive FDA news gradual riser throughout the day, actually tempted to go long on this breakout…too late now, hope fofr it to get extended to make it a short

And then there’s a whoooooooooole bunch of stocks that have gotten crushed and people are picking up as rebound plays, all are potential shorts if their rebounds continue/get extended like GIGM seems to be trying to accomplish…reserve shares at will

ALTI—news ain’t shit, frggin fraud, shhhhhh don’t tell the believers

TSTR—please get close to bigtime resistance at $4!

NURO—duhhh, look at me, I’m a failing biotech, duhhhhhh

CALP—haha nice spike attempt you lil bitch

NKTR—another NURO, c’mon, keep the dead cat bounce up

LEE—down more, spike less, means it can’t even bottom, maybe I’ll be aggressive with this one

ABAT & VLNC—battery BSers in freefall, trying to make one last charge..hehehe…shutup Sykes

EXEL—gonna be a nice short, c’mon just 1-2 more days of laughable spiking attempts!

DAN—up on an ANALyst comments, need I say more?

IMMR—immerse yourself in this horrific chart

DXCM—last and least


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Timothy Sykes



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia